Wayne Williams Buys 10,810 Shares of Callan JMB (NASDAQ:CJMB) Stock

Callan JMB Inc. (NASDAQ:CJMBGet Free Report) CEO Wayne Williams purchased 10,810 shares of the company’s stock in a transaction that occurred on Monday, December 15th. The shares were acquired at an average cost of $1.70 per share, with a total value of $18,377.00. Following the completion of the purchase, the chief executive officer owned 79,355 shares of the company’s stock, valued at $134,903.50. The trade was a 15.77% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.

Callan JMB Price Performance

CJMB traded down $0.07 during trading on Monday, reaching $1.71. 39,741 shares of the company’s stock were exchanged, compared to its average volume of 45,032. Callan JMB Inc. has a fifty-two week low of $1.20 and a fifty-two week high of $7.76. The company’s fifty day moving average price is $3.34 and its 200-day moving average price is $4.34.

Callan JMB (NASDAQ:CJMBGet Free Report) last issued its quarterly earnings data on Friday, November 14th. The company reported ($0.61) earnings per share (EPS) for the quarter. Callan JMB had a negative net margin of 112.72% and a negative return on equity of 133.43%. The business had revenue of $1.45 million during the quarter.

Hedge Funds Weigh In On Callan JMB

A hedge fund recently bought a new stake in Callan JMB stock. HighTower Advisors LLC bought a new stake in Callan JMB Inc. (NASDAQ:CJMBFree Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 12,500 shares of the company’s stock, valued at approximately $56,000. HighTower Advisors LLC owned about 0.28% of Callan JMB as of its most recent filing with the Securities and Exchange Commission.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Callan JMB in a research report on Monday, December 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Callan JMB presently has an average rating of “Sell”.

Get Our Latest Stock Analysis on Callan JMB

About Callan JMB

(Get Free Report)

Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.

Further Reading

Insider Buying and Selling by Quarter for Callan JMB (NASDAQ:CJMB)

Receive News & Ratings for Callan JMB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Callan JMB and related companies with MarketBeat.com's FREE daily email newsletter.